Discover how understanding your viral load and CD4 count puts you in control of HIV treatment and transforms confusing ...

In a study of human immune cells infected with HIV, the virus that causes AIDS, scientists at Johns Hopkins Medicine say a ...

Gene therapy may be a crucial tool to put HIV to sleep permanently, providing a lasting and durable treatment against the v ...

There are two ways that HIV patients’ bodies can keep the virus under control after they stop antiretroviral therapy, a new ...

A new nanozyme-powered TB test improves detection in people with HIV, offering rapid, electricity-free diagnosis via a beetle-inspired chip.

HIV remains incurable but manageable. Johns Hopkins found a way to silence it long-term using a molecule from the virus ...

CD4 + T cells are the main targets of HIV-1 in the host. The magnitude of viral replication in these cells is closely linked to their activation state: in activated memory CD4 + T cells HIV-1 ...

Gilead’s HIV treatment trials involving GS-1720 and GS-4182 have been put on clinical hold by the Food and Drug Administration.

Liyab Aguingay Treatment Hub in Sorsogon addresses the healthcare needs of individuals with HIV in the Province of Sorsogon.

Provincial Health Office OIC Dr. Fruserma Mary Uy during the training on responsible messaging about HIV to Bohol media practitioners on June 20, stressed the vital role of media in shaping public ...